Form 4: Zevra Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Rahsaan Thompson, Chief Legal & Compliance of Zevra Therapeutics, Inc., sold 42,666 shares of common stock on August 14, 2026 for $11.13 per share.
Summary
- Open-market sale: disposed of 42,666 Common Stock at $11.13 ($474,774) on August 14, 2026; holds 37,569 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $474,774 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Rahsaan Thompson — Officer (Chief Legal & Compliance)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market sale | Common Stock | 42,666 | $11 | $474.8K | 37,569 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market sale (42,666 shares) |
Keywords
insider transaction, Form 4, ZVRA, ZEVRA THERAPEUTICS, INC., bearish, Rahsaan Thompson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.